首页 | 本学科首页   官方微博 | 高级检索  
     

脑心通胶囊治疗慢性心力衰竭68例临床观察
引用本文:万启南,肖政. 脑心通胶囊治疗慢性心力衰竭68例临床观察[J]. 中西医结合心脑血管病杂志, 2004, 2(3): 127-128
作者姓名:万启南  肖政
作者单位:云南中医学院附属医院
摘    要:目的观察脑心通胶囊对慢性心力衰竭(CHF)的临床治疗效果,并探讨其作用机制.方法 133例CHF病人被随机分成脑心通治疗组68例和洛汀新(盐酸贝那普利)治疗组65例,前者给予脑心通胶囊4粒,每日3次,后者给予洛汀新10 mg,每日1次,两组疗程皆为6个月.治疗后观察病人临床症状体征、心功能参数及心功能分级情况的变化.结果两组病人治疗后临床症状、体征、心功能参数及心功能分级情况较自身治疗前比较有明显改善(P<0.05),但组间比较两组病人的临床症状、体征、心功能参数及心功能分级改变无统计学意义(P>0.05).结论脑心通胶囊同洛汀新都能有效治疗CHF,阻断和逆转CHF病情发展.

关 键 词:脑心通胶囊  慢性心力衰竭  洛汀新
文章编号:1672-1349-(2004)03-0127-02
修稿时间:2003-12-23

Clinical Observation of Chronic Heart Failure Treated by Naoxintong Capsule 68 Cases Report
Wan qiNan,Xiao Zheng The Affiliated Hospital of Yunnan TCM College. Clinical Observation of Chronic Heart Failure Treated by Naoxintong Capsule 68 Cases Report[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2004, 2(3): 127-128
Authors:Wan qiNan  Xiao Zheng The Affiliated Hospital of Yunnan TCM College
Affiliation:Kunming 650021
Abstract:Objective To observe clinical therapy effect of Tongxinluo capsule on CHF and explore its effect mechanism.Methods 133 CHF patients were divided into Naoxintong treatment group(68 cases) and Lotensin contrast group(65 cases).The treatment group was given Naoxintong capsule 4 grain tidpo and the contrast group was given Lotensin 10mg qdpo.The period of treatment of two groups was 6 months all.After treatment,to observe clinical symptom,physical sign,heart function parameter,and heart function classification.Results Two groups had obvious improvement after treatment than before treatment in those parameters,however two group had no statistics meaning.Conclusion Naoxintong capsuleand Lotensin all had effect on CHF and could resist and reverse CHF development.
Keywords:naoxintong capsule  chronical heart failure  benazepril  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号